Dermata Therapeutics (DRMA) P/E (2021 - 2026)
Dermata Therapeutics (DRMA) P/E from Aug 13, 2021 to Jun 3, 2026. The TTM Dermata Therapeutics (DRMA) P/E is -0.22. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of Dermata Therapeutics (DRMA)
| Year | P/E | Change |
|---|---|---|
| 2026 | -0.22 | -13.76% |
| 2025 | -0.25 | -81.40% |
| 2024 | -1.36 | -27.49% |
| 2023 | -1.87 | -68.18% |
| 2022 | -5.89 | -49.01% |
| 2021 | -11.55 | N/A |
Comparison Dermata Therapeutics (DRMA) P/E with competitors
Dermata Therapeutics (DRMA) P/E is -0.22.